{"id":"W4394821030","doi":"10.3899/jrheum.2023-1062","title":"Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)","year":2024,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Celgene; Biogen; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Adverse effect; Placebo; Internal medicine; Randomized controlled trial; Rheumatology; Concomitant; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00366995,0.0004142585,0.001087229,0.0002169301,0.0003009146,0.0004879381,0.0003401646,0.0006133638,0.001039484],"category_scores_gemma":[0.00130112,0.0001930824,0.001141523,0.0003205607,0.0003538762,0.000425102,0.0003150336,0.0007354674,0.0001487373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005223336,"about_ca_system_score_gemma":0.000880504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006508965,"about_ca_topic_score_gemma":0.002695158,"domain_scores_codex":[0.9991615,0.0003700982,0.00008557436,0.0001030703,0.0001496178,0.0001302059],"domain_scores_gemma":[0.9985183,0.0002759148,0.0007338164,0.00009165364,0.0001266591,0.0002536081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6912373,0.01116252,0.1144087,0.001515333,0.004460018,0.0003213195,0.000163311,0.001955105,0.0110066,0.0002486052,0.002164284,0.161357],"study_design_scores_gemma":[0.1778655,0.5134695,0.2877784,0.0002088148,0.005298053,0.001436703,0.0001415714,0.002461108,0.006646049,0.0002332819,0.004390305,0.00007077699],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943252,0.004199214,0.0002619405,0.00008368626,0.00003084505,0.0002475063,0.0003328446,0.00001185286,0.0005068258],"genre_scores_gemma":[0.9971969,0.001091656,0.0003248373,0.0002076924,0.00005808537,0.0001996838,0.0005775408,0.000002019634,0.0003415039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00366995,"threshold_uncertainty_score":0.01940876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0166119141582313,"score_gpt":0.2947634126763163,"score_spread":0.278151498518085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}